There is no goods in the shopping cart !
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 0-9
Your Position: Home > IGF-II


IGF-II Molecule Information

Name:Insulin-like growth factor II
Target Synonym:Insulin-like growth factor II;Preptin;T3M-11-derived growth factor;IGF2;IGF-II;Insulin-like growth factor II Ala-25 Del;Somatomedin-A
Number of Launched Drugs:0
Number of Drugs in Clinical Trials:2
Lastest Research Phase:Phase ?

IGF-II Protein Product ListCompare or Buy

By Product Status:
By Product Category:
By Species:
Cat. No. Species Product Description Structure Purity Feature
IG2-H82F9 Human Biotinylated Human IGF-II Protein, Avitag™,Fc Tag
IG2-H4260 Human Human IGF-II Protein, Fc Tag

IGF-II Part of Bioactivity data

Human IGF-II, Fc TagHuman IGF-II, Fc Tag (Cat. No. IG2-H4260) ELISA bioactivity

Immobilized Human IGFBP-3, His Tag (Cat. No. IG3-H5229) at 0.5 μg/mL (100 μL/well) can bind Human IGF-II, Fc Tag (Cat. No. IG2-H4260) with a linear range of 1-20 ng/mL (QC tested).

Biotinylated Human IGF-II, Avitag,Fc TagBiotinylated Human IGF-II, Avitag,Fc Tag (Cat. No. IG2-H82F9) ELISA bioactivity

Immobilized Human IGFBP-3, His Tag (Cat. No. IG3-H5229) at 5 μg/mL (100 μL/well) can bind Biotinylated Human IGF-II, Avitag,Fc Tag (Cat. No. IG2-H82F9) with a linear range of 0.008-0.1 μg/mL (QC tested).

IGF-II Molecule Synonym Name


IGF-II Molecule Background

Insulin-like growth factor 2 (IGF-2) is also known as Somatomedin-A, IGF-II, PP9974, and is one of three protein hormones that share structural similarity to insulin. IGF-2 exerts its effects by binding to the IGF-1 receptor. IGF2 may also bind to the IGF-2 receptor (also called the cation-independent mannose 6-phosphate receptor), which acts as a signalling antagonist; that is, to prevent IGF2 responses. The major role of IGF2 is as a growth promoting hormone during gestation. In the process of Folliculogenesis, IGF2 is created by Theca cells to act in an autocrine manner on the theca cells themselves, and in a paracrine manner on Granulosa cells in the ovary. IGF2 promotes granulosa cell proliferation during the follicular phase of the menstrual cycle, acting alongside Follicle Stimulating Hormone (FSH). After ovulation has occurred, IGF-2 promotes progesterone secretion during the luteal phase of the menstrual cycle together with Luteinizing Hormone (LH). Thus, IGF2 acts as a Co-hormone together with both FSH and LH. IGF-2 may play a key role in memory and could potentially be used to treat Alzheimer's Disease. It is sometimes produced in excess in islet cell tumours, causing hypoglycemia. Doege-Potter syndrome is a paraneoplastic syndrome in which hypoglycemia is associated with the presence of one or more non-islet fibrous tumors in the pleural cavity. has been shown to interact with IGFBP3 and Transferrin.

IGF-II References

IGF-II Clinical Drug Information

Name Research Code Research Phase Company Indications Clinical Trials
Xentuzumab BI-836845 Phase Ⅱ Boehringer Ingelheim Non small cell lung cancer (NSCLC), Prostate cancer, Breast cancer, Solid tumours Details
Dusigitumab MEDI-573 Phase Ⅱ MedImmune Breast cancer Details

This web search service is supported by Google Inc.